CHEMBIO DIAGNOSTICS INC's ticker is CEMI and the CUSIP is 163572209. A total of 62 filers reported holding CHEMBIO DIAGNOSTICS INC in Q3 2020. The put-call ratio across all filers is 0.99 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $137,000 | -15.4% | 54,662 | 0.0% | 0.00% | – |
Q2 2021 | $162,000 | -31.1% | 54,662 | -18.5% | 0.00% | – |
Q1 2021 | $235,000 | -26.3% | 67,088 | 0.0% | 0.00% | – |
Q4 2020 | $319,000 | -2.1% | 67,088 | 0.0% | 0.00% | – |
Q3 2020 | $326,000 | +49.5% | 67,088 | 0.0% | 0.00% | – |
Q2 2020 | $218,000 | -36.4% | 67,088 | 0.0% | 0.00% | – |
Q1 2020 | $343,000 | +12.1% | 67,088 | 0.0% | 0.00% | – |
Q4 2019 | $306,000 | +0.7% | 67,088 | +34.9% | 0.00% | – |
Q3 2019 | $304,000 | +15.6% | 49,734 | +15.2% | 0.00% | – |
Q2 2019 | $263,000 | – | 43,189 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Penbrook Management LLC | 344,060 | $1,634,000 | 1.26% |
Union Square Park Capital Management, LLC | 400,000 | $1,900,000 | 0.76% |
P.A.W. CAPITAL CORP | 100,000 | $475,000 | 0.42% |
PRECEPT MANAGEMENT LLC | 150,000 | $713,000 | 0.29% |
Newbridge Financial Services Group, Inc. | 73,500 | $349,000 | 0.29% |
SANDERS MORRIS HARRIS LLC | 183,584 | $990,000 | 0.22% |
FRIESS ASSOCIATES LLC | 555,000 | $2,636,000 | 0.19% |
PERRITT CAPITAL MANAGEMENT INC | 30,651 | $146,000 | 0.09% |
Ikarian Capital, LLC | 219,109 | $1,041,000 | 0.05% |
SEGALL BRYANT & HAMILL, LLC | 705,823 | $3,352,000 | 0.04% |